Allspring Global Investments Holdings, LLC Rigel Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$1.07 - $1.39 $112,421 - $146,043	105,067 New	105,067 $113,000
Q2 2023 Jul 18, 2023	SELL	$1.12 - $1.82 $7,665 - $12,456	-6,844 Reduced 7.74%	81,541 $105,000
Q1 2023 Apr 13, 2023	BUY	$1.25 - $2.0 $23,075 - $36,920	18,460 Added 26.4%	88,385 $116,000
Q4 2022 Jan 23, 2023	BUY	$0.67 - $11.9 $23,442 - $416,369	34,989 Added 100.15%	69,925 $105 Million
Q3 2022 Oct 26, 2022	BUY	$1.1 - $12.2 $20,263 - $224,736	18,421 Added 111.54%	34,936 $41,000
Q2 2022 Jul 25, 2022	SELL	$0.67 - $3.19 $154,508 - $735,642	-230,609 Reduced 93.32%	16,515 $18,000
Q1 2022 May 02, 2022	SELL	$2.22 - $3.45 $104,801 - $162,867	-47,208 Reduced 16.04%	247,124 $738,000
Q4 2021 Jan 28, 2022	BUY	$2.36 - $3.57 $694,623 - $1.05 Million	294,332 New	294,332 $779,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account